Partial hydatidiform mole

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:254693O01.1
Who is this for?
Show terms as
4Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

A partial hydatidiform mole (also called partial molar pregnancy or incomplete hydatidiform mole) is an abnormal form of pregnancy in which a non-viable fertilized egg implants in the uterus and develops into a mass of abnormal tissue rather than a healthy fetus. It occurs when a normal egg is fertilized by two sperm simultaneously (dispermy), resulting in a triploid karyotype (typically 69,XXX or 69,XXY), with two sets of paternal chromosomes and one set of maternal chromosomes. Unlike a complete hydatidiform mole, a partial mole may contain some identifiable fetal or embryonic tissue alongside the abnormal placental tissue characterized by focal swelling of chorionic villi and trophoblastic hyperplasia. The condition primarily affects the reproductive system. Key symptoms include vaginal bleeding during the first or second trimester, a uterus that may be smaller than expected for gestational age, abnormally elevated (though often less dramatically than in complete moles) levels of human chorionic gonadotropin (hCG), and ultrasound findings showing a mixture of cystic placental tissue and possible fetal parts. Patients may also experience nausea, vomiting, and pelvic discomfort. Pre-eclampsia may occasionally develop, though less commonly than with complete moles. Treatment involves surgical evacuation of the uterine contents, typically by suction curettage. Following evacuation, serial monitoring of serum hCG levels is essential to ensure complete resolution and to detect any persistent gestational trophoblastic disease. The risk of progression to gestational trophoblastic neoplasia (including invasive mole or, rarely, choriocarcinoma) is approximately 0.5–5%, which is lower than the risk associated with complete hydatidiform moles. Patients are generally advised to avoid pregnancy during the hCG monitoring period, which typically lasts six months to one year. Prognosis is generally excellent with appropriate follow-up, and most women can have successful subsequent pregnancies.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Partial hydatidiform mole.

View clinical trials →

No actively recruiting trials found for Partial hydatidiform mole at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Partial hydatidiform mole community →

Specialists

4 foundView all specialists →
IM
Ignatia B Van den Veyver, MD
Specialist
PI on 3 active trials1 Partial hydatidiform mole publication
JM
Jackie Ross, MD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Partial hydatidiform mole.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Partial hydatidiform moleForum →

No community posts yet. Be the first to share your experience with Partial hydatidiform mole.

Start the conversation →

Latest news about Partial hydatidiform mole

No recent news articles for Partial hydatidiform mole.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Partial hydatidiform mole

What is Partial hydatidiform mole?

A partial hydatidiform mole (also called partial molar pregnancy or incomplete hydatidiform mole) is an abnormal form of pregnancy in which a non-viable fertilized egg implants in the uterus and develops into a mass of abnormal tissue rather than a healthy fetus. It occurs when a normal egg is fertilized by two sperm simultaneously (dispermy), resulting in a triploid karyotype (typically 69,XXX or 69,XXY), with two sets of paternal chromosomes and one set of maternal chromosomes. Unlike a complete hydatidiform mole, a partial mole may contain some identifiable fetal or embryonic tissue alongsi

How is Partial hydatidiform mole inherited?

Partial hydatidiform mole follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Partial hydatidiform mole typically begin?

Typical onset of Partial hydatidiform mole is adult. Age of onset can vary across affected individuals.

Which specialists treat Partial hydatidiform mole?

4 specialists and care centers treating Partial hydatidiform mole are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.